Renal Dialysis Market size was valued at USD 19.55 Billion in 2023. The Renal Dialysis Market is projected to grow from USD 20.66 Billion in 2024 to USD 30.47 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.97% during the forecast period (2024 - 2032).
The Renal Dialysis Market is emerging due to the growing prevalence of chronic kidney disease (CKD), rising R&D expenditure for developing new dialysis products, and the increasing geriatric population. Additionally, gaining momentum toward home hemodialysis and peritoneal dialysis will provide growth opportunities for the market in the future. However, the high cost of dialysis treatment might hamper the market's growth in the forecast period.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The renal dialysis market has been experiencing steady growth, driven by various factors. One of the primary drivers is the growing prevalence of chronic kidney disease (CKD), which has been on the rise due to factors like diabetes, hypertension, and an aging population. For instance, according to the Centres for Disease Control and Prevention (US),35.5 million US adults, or 14%, or more than 1 in 7 are predicted to have CKD by 2023. Similarly, according to a review article published in 2022 on the epidemiology of chronic kidney disease, chronic kidney disease is a progressive condition that affects more than 10% of the global population, or more than 800 million people. The increasing awareness and availability of better diagnostic tools have also contributed to the early detection and diagnosis of CKD, prompting timely interventions like renal dialysis.
Moreover, the expanding geriatric population, coupled with rising healthcare expenditure and favourable reimbursement policies, has made renal dialysis services more accessible to a larger portion of the population. Continuous research and development efforts have led to the introduction of innovative dialysis modalities and therapies, further propelling market growth. For instance, Cutting-edge technologies, such as wearable and portable dialysis devices, have emerged from these initiatives, offering greater mobility and convenience for patients. In April 2023, Medtronic plc (US) and DaVita Inc (US) launched Mozarc Medical. It holds tremendous promise to improve the lives of patients living with kidney disease as it seeks to revolutionize the approach to home dialysis by improving accessibility, ease of use, and clinical performance.
Additionally, dialysis service providers have expanded their operations into emerging markets, broadening the reach of dialysis services to underserved regions. Together, these factors have created a conducive environment for the renal dialysis market's expansion, providing essential treatments for patients with CKD and end-stage renal disease.
The global renal dialysis’ segmentation, based on type of dialysis, includes primary dialysis and secondary dialysis. Primary dialysis includes hemodialysis, hemofiltration, and peritoneal dialysis. The primary dialysis segment accounted for the largest market share in 2022 due to the rising prevalence of chronic kidney diseases (CKD), the shortage of kidneys for transplantation, and technological advancements. As per the World Kidney Day 2022 Campaign, 1 in 10 people worldwide is diagnosed with CKD, and further, it revealed that kidney disease-related mortality is persistently increasing and that by 2040, it will be the 5th leading cause of death globally. Additionally, secondary dialysis includes hemodiafiltration (HDF) and intestinal dialysis. Secondary dialysis is a backup and rescue therapy for primary dialysis, and the factors influencing its growth are the benefits of HDF over hemodialysis and increasing awareness of HDF. Moreover, the rise in product launches is associated with technology-based hemodiafiltration.
Therefore, increasing incidences of CKD, a rising number of PDs performed, and technologically advanced product launches are fueling the growth of the type of dialysis segment.
The Renal Dialysis market segmentation, based on Dialysis Products, includes dialysis machines, dialyzers, dialysis concentrates, dialysis catheters, and others. The Dialysis Machines segment held the largest market share in 2022 and fastest growing segment during the forecast period i.e., 2023 -2032. Dialysis machines are one of the main products utilized in renal dialysis, also known as artificial kidney dialysis. Market players are launching innovative dialysis machines for all age groups, including adults and pediatrics. For instance, in December 2020, Medtronic plc (Ireland) launched a pediatric and neonatal acute dialysis machine that was successfully installed at Cincinnati Children's Hospital Medical Center (US). Moreover, dialyzers are of two types: single-use dialyzers and reuse dialyzers. The demand for dialyzers is frequently increasing owing to end-stage kidney disease because at this level there are macro-sized proteins that can diminish the dialyzer in a short span of time.
Furthermore, the demand for dialysis concentrates is increasing owing to the rising incidences of chronic kidney diseases (CKD) and acute kidney diseases (AKD), which are mainly led by the growing geriatric population and are creating lucrative growth opportunities. The dialysis concentrators are used to reduce the volume of fluid that is usually discarded and improve the efficiency of dialysis treatment.
Hence, increasing product launches in order to fulfill the needs of customers, rising renal failure cases across the globe, and a growing geriatric population are fostering the growth of the dialysis product segment.
Figure 2: Renal Dialysis Market, by Dialysis Product, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Renal Dialysis Market has been segmented, based on end user into hospitals & clinics, dialysis centers, and home care settings. A large market share was held by hospitals & clinics in 2022 due to the high incidence of CKD and AKD across the globe. A majority of people prefer hospitals & clinics as advanced treatment for various kidney diseases owing to the availability of specialists and availability of technologically advanced dialysis products among others. The presence of indispensable players in a large and expanding market such as Rockwell Medical, Inc. (US) and Fresenius Kabi AG (Germany). Rockwell Medical, Inc. (US) currently serves 1700+ dialysis clinics and is one of two manufacturers and suppliers with the scalability and transportation infrastructure to service the 7,200+ dialysis clinics in the US, as well as selected international markets, in 2023. Moreover, Fresenius Kabi AG (Germany) is the world's leading provider of dialysis products and services, serving 345,000 patients in over 4,100 clinics.
Furthermore, a dialysis center is a type of medical facility where patients with chronic kidney failure can receive dialysis treatments. Dialysis centers’ growth has been driven by the availability of medical coverage from private and government organizations. Private organizations such as DaVita (US) and Fresenius Kabi AG (Germany), have collaborations with the government and provide plans including Employer group health plans, Individual coverage, Medicare, including original Medicare and Medicare Advantage, Medicaid, and Medicare supplement plans (medigap), propelling segment growth during the forecast period.
Thus, increasing incidences of the end-renal stage disease, major market players’ collaboration with hospitals & clinics, a growing elderly population, and high awareness of medical coverage are fostering the end user segment's growth.
By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America Renal Dialysis accounted for the largest market share of 39.19% in 2022 and is anticipated to reach approximately USD 10.94 billion by 2032 at a 4.68% CAGR during the forecast period. However, Asia-Pacific is projected to grow at the highest CAGR of 7.23% during the forecast period.
The outlook for the North America Renal Dialysis market remains promising, with sustained growth anticipated. Investments in healthcare infrastructure and a growing awareness of advanced medical solutions are expected to drive market expansion further. Both established players and emerging entrants are poised to capitalize on these opportunities, leveraging technological advancements to meet the rising demand for improved surgical outcomes.
The Europe Renal Dialysis’ market is currently undergoing substantial growth, driven by a confluence of factors that include technological advancements, an aging population, and a surge in surgical procedures. This dynamic landscape is witnessing notable innovations in renal dialysis solutions, leading to enhanced efficacy and improved patient outcomes. The integration of advanced renal dialysis ultimately leads to enhanced patient care. This transformative journey aligns with broader goals of advancing healthcare technologies and ensuring better surgical outcomes, positioning Europe as a key player in the global market and contributing to the ongoing enhancement of healthcare delivery and patient well-being across the continent.
Further, the major countries will be study are US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: RENAL DIALYSIS MARKET BY REGION 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Asia-pacific Renal Dialysis market accounted for USD 4.35 billion in 2022 and is projected to grow at a CAGR of 7.23% during the forecast period. Asia-Pacific is further segmented into the China, India, Japan, South Korea, Australia, and Rest of Asia-Pacific. Additionally, the growing geriatric population, who are more prone to surgical procedures, further contributes to the market expansion.
The Asia Pacific Renal Dialysis market is projected to experience significant growth in the coming years. Factors such as the increasing number of Chronic Kidney Disease, R&D expenditure, and technological advancements in dialysis procedures are expected to drive market growth.
The Rest of the World Renal Dialysis market accounted for USD 1.50 Billion in 2022 and is projected to grow at a CAGR of 6.12% during the forecast period. Rest of the World is further segmented into the Middle East, Africa & Latin America.
The demand for Renal Dialysisis on the ascent, given their pivotal role in treating chronic kidney diseases. Moreover, the introduction of cutting-edge technologies and continual product innovations are contributing significantly to the market's expansion, enhancing the overall effectiveness of these medical solutions. In these regions, where healthcare infrastructure is evolving rapidly, the adoption of Renal Dialysisis gaining momentum, driven by a growing awareness of their benefits.
The Renal Dialysis Market is distinguished by the presence of many global, regional, and local players. The increasing prevalence of chronic kidney disease (CKD), the rising R&D expenditure for developing new dialysis products, and the increasing geriatric population are further expected to drive the growth of the Renal Dialysis Market during the forecast period. However, the high cost of dialysis treatment may hamper the growth of the Renal Dialysis Market. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their devices and signing contracts and agreements to broaden their reach and reduce operational costs. The Renal Dialysis Market is extremely competitive, with players competing, partnering, and investing heavily in R&D to gain a significant market share. The market is moderately fragmented with rising competition, product launches, increasing collaborative partnerships, and other strategic decisions to achieve operational efficiency.
Baxter, a global healthcare company, offers medical supplies and surgical instruments to the healthcare sector is focusing on access to insight-driven innovation and services for dialysis Digital health platforms for essential care, with support for patient monitoring and electronic medical records (EMR) for in-center dialysis patient care, has increased patient convenience.
Furthermore, in May 2020, Baxter (US) and Mayo Clinic (US) collaborated to establish a center of excellence for renal care and to enhance the treatment of patients with severe and complicated conditions.
North America
Europe
Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Attribute/Metric | Details |
| Market Size 2023 | USD 19.55 Billion |
| Market Size 2024 | USD 20.66 Billion |
| Market Size 2032 | USD 30.47 Billion |
| Compound Annual Growth Rate (CAGR) | 4.97% (2024-2032) |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2018 to 2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type of Dialysis, Dialysis Products, End Users, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Becton, DICKINSON, and Company (US) B. Braun SE (Germany) Cantel Medica (US) Nipro Europe Group Companies (Belgium) Nikkiso Co., Ltd (Japan) Fresenius Medical Care AG & Co. KGaA (Germany) Baxter (US) Medtronic (Ireland) Jordan Medical Solutions (Jordan) Asahi Kasei Corporation (Japan) |
| Key Market Opportunities | · Gaining momentum toward Home Hemodialysis and Peritoneal Dialysis |
| Key Market Drivers | · Growing Prevalence of Chronic Kidney Disease (CKD) · Rising R&D expenditure for developing new dialysis products |
Frequently Asked Questions (FAQ) :
The Renal Dialysis Market is anticipated to reach 30.47 billion during the forecast period of 2024-2032.
The US is expected to hold a 82.87% share of the North America market.
The Renal Dialysis market is expected to grow at a 4.97% CAGR during the forecast period from 2024 to 2032.
The North America region market is estimated to hold the largest market share in the Renal Dialysis ‘s market.
Becton, DICKINSON, and Company (US), B. Braun SE (Germany), Cantel Medica (US), Nipro Europe Group Companies (Belgium), Nikkiso Co., Ltd (Japan)
The Dialysis machine led the product market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
